Phase I study of SU011248 [sunitinib] in combination with oxaliplatin, leucovorin [folinic acid], and 5-fluorouracil [fluorouracil] in patients with advanced solid malignancies.
Phase of Trial: Phase I
Latest Information Update: 21 Jul 2015
At a glance
- Drugs Fluorouracil; Folinic acid; Oxaliplatin; Sunitinib
- Indications Colorectal cancer; Solid tumours
- Focus Adverse reactions
- Sponsors Pfizer
- 17 Jul 2009 Actual number of patients (53) added as reported by ClinicalTrials.gov.
- 01 May 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 01 Jan 2009 Planned end date changed from 1 Oct 2008 to 1 Nov 2008.